Animal Aids Market By Product Type (Medicinal Products, Nutritional Supplements, Diagnostic Products, Surgical Equipment, Wound Care Products) , By Animal Type (Companion Animals, Livestock Animal, Wildlife Animal.) By End User (Veterinary Clinics and Hospitals, Animal Shelters and Rescue Center, Farms and Ranches, Pet Owners) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The animal aids market was valued at $0.9 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
Animal aids are tools, devices, and services designed for the well-being of animals. These can range from medical aids like prosthetics and wheelchairs to behavioral aids such as training tools and enrichment toys. Veterinary services and therapeutic treatments are also covered under animal aids, which ensure that animals receive the care and support, thus promoting animal welfare.
The growth of the global animal aids market is driven by rise in pet ownership and increase in public awareness and concern for the well-being of animals. According to the 2024 statistics determined by Forbes Advisor—a U.S.-based business magazine—approximately 86.9 million homes in the U.S. own a pet. With increasing adoption of pets, the demand for animal care products and services is expected to rise simultaneously, thereby fostering the growth of the animal aids market. Furthermore, increase in lifespan of pets and surge in disposable income encourage pet owners to spend more on their pets' health and well-being, thus boosting the sale of medical and supportive aids. Moreover, increase in penetration of wearable technology and smart feeding systems notably contributes toward the growth of the market. For instance, devices such as GPS trackers and health monitors are being used to track the daily activities for pets. In addition, pet owners are increasingly turning to automated feeders and water dispensers that can be controlled via smartphone apps, providing convenience and ensuring their pets are fed and hydrated on schedule even when they are not home. However, high costs associated with advanced animal aids and veterinary treatments and dearth of veterinary professionals trained in using and prescribing advanced animal aids significantly restrain the growth of the market. On the contrary, supportive government policies promoting animal health and welfare are expected to offer lucrative opportunities for the expansion of the global market during the forecast period. For instance, the World Organisation for Animal Health (WOAH) aims to improve global animal health and welfare by enhancing the capacity of veterinary services. Furthermore, increase in penetration of remote monitoring services for pets is expected to open new avenues for the market growth in the coming years.
The global animal aids market is segmented into product type, animal type, end user, and region. On the basis of product type, the market is divided into medicinal products, nutritional supplements, diagnostic products, surgical equipment, and wound care products. By animal type, it is classified into companion animals, livestock animal, and wildlife animal. Depending on end user, it is categorized into veterinary clinics & hospitals, animal shelters & rescue centers, farms & ranches, and pet owners. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key FindingsBy product type, the medicinal product segment accounted for the largest share in 2023 in the animal aids market.
Depending on animal type, the companion animal segment was the major shareholder in 2023.
On the basis of end user, the veterinary clinics & hospitals segment dominated the market in 2023.
Region wise, North America was the key revenue contributor in 2023, and is expected to dominate the market in the coming years.
Competition AnalysisCompetitive analysis and profiles of the major players in the global animal aids market include Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health, Bayer Animal Health, CEVA Santé Animale S.A.S., Virbac, Vetoquinol, Dechra Pharmaceuticals Plc., and Phibro Animal Health Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.
Key Market SegmentsBy Product TypeMedicinal Products
Nutritional Supplements
Diagnostic Products
Surgical Equipment
Wound Care Products
By Animal TypeCompanion Animals
Livestock Animal
Wildlife Animal.
By End UserVeterinary Clinics and Hospitals
Animal Shelters and Rescue Center
Farms and Ranches
Pet Owners
By RegionNorth America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Zoetis Inc.
Boehringer Ingelheim Animal Health
Elanco Animal Health
Merck Animal Health
Bayer Animal Health
CEVA Santé Animale S.A.S.
Virbac
Vetoquinol
Dechra Pharmaceuticals plc.
Phibro Animal Health Corporation.